Design of multi-epitope vaccine based on G2c genotype PEDV antigen and its immunogenicity and protective effect in piglets.
- 1West China College of Basic Medicine and Forensic Medicine, Sichuan University, Chengdu, China.
- 2Department of Biological Medicine, Xihua University, Chengdu, China.
- 3Chengdu Textile College, Chengdu, China.
Abstract
Porcine epidemic diarrhea virus (PEDV) remains a clinically important enteric virus, causing diarrhea, vomiting, dehydration, and high mortality in piglets. As the currently available vaccines may provide inconsistent protection against genetically heterogeneous field strains, particularly G2c variants, improved immunization strategies are still needed. In this study, a multi-epitope vaccine candidate was designed from the PEDV S, M, and N proteins using an immunoinformatics-based workflow. The final construct incorporated 8 linear B-cell epitopes, 1 CTL epitope, and 5 HTL epitopes, and was predicted to contain 6 discontinuous B-cell epitopes; porcine β-defensin-1 (PBD-1) was used as an adjuvant component and attached to the N-terminus. Computational analyses indicated favorable antigenicity, solubility, and structural stability. In vivo evaluation showed that the SMN peptide vaccine elicited PEDV-specific IgG, IgA, cytokine, and neutralizing-antibody responses. Following challenge with a virulent G2c PEDV strain, all five piglets in each peptide-vaccinated group survived, compared with three of five piglets in the commercial inactivated-vaccine group and none of the five piglets in the PBS group. These results indicate that the MEV candidate induced immune responses and improved protective outcomes in piglets, supporting its further development as a PEDV vaccine.
Related
- In Silico Design and Immunogenicity Studies of Two Multi-Epitope Vaccines against Klebsiella pneumoniae.
- Conservation guided reverse vaccinology for the design of a broadly immunogenic multi-epitope vaccine against monkeypox virus
- Integrated immunoinformatics and molecular dynamics approaches reveal a promising multi-epitope vaccine against hantavirus
- Immunoinformatics design and in vitro evaluation of dendritic cell-targeting brucellosis multi-epitope vaccine based on Omp28 and GroEL
- Rational design of a multi-epitope vaccine targeting the stress-associated proteins for Mycoplasma fermentans via immunoinformatics
BibTeX
@article{luo2026design,
title = {{Design of multi-epitope vaccine based on G2c genotype PEDV antigen and its immunogenicity and protective effect in piglets.}},
author = {Hao Luo and Zaixing Sun and Jingxin Wang and Lin Lan and Baoning Wang},
journal = {Frontiers in veterinary science},
year = {2026},
month = oct,
doi = {10.3389/fvets.2026.1942409},
url = {https://europepmc.org/article/MED/42923521},
note = {CC BY},
}
RIS
TY - JOUR
TI - Design of multi-epitope vaccine based on G2c genotype PEDV antigen and its immunogenicity and protective effect in piglets.
AU - Hao Luo
AU - Zaixing Sun
AU - Jingxin Wang
AU - Lin Lan
AU - Baoning Wang
PY - 2026
DA - 2026/10/08
JO - Frontiers in veterinary science
DO - 10.3389/fvets.2026.1942409
UR - https://europepmc.org/article/MED/42923521
AB - Porcine epidemic diarrhea virus (PEDV) remains a clinically important enteric virus, causing diarrhea, vomiting, dehydration, and high mortality in piglets. As the currently available vaccines may provide inconsistent protection against genetically heterogeneous field strains, particularly G2c variants, improved immunization strategies are still needed. In this study, a multi-epitope vaccine candidate was designed from the PEDV S, M, and N proteins using an immunoinformatics-based workflow. The final construct incorporated 8 linear B-cell epitopes, 1 CTL epitope, and 5 HTL epitopes, and was predicted to contain 6 discontinuous B-cell epitopes; porcine β-defensin-1 (PBD-1) was used as an adjuvant component and attached to the N-terminus. Computational analyses indicated favorable antigenicity, solubility, and structural stability. In vivo evaluation showed that the SMN peptide vaccine elicited PEDV-specific IgG, IgA, cytokine, and neutralizing-antibody responses. Following challenge with a virulent G2c PEDV strain, all five piglets in each peptide-vaccinated group survived, compared with three of five piglets in the commercial inactivated-vaccine group and none of the five piglets in the PBS group. These results indicate that the MEV candidate induced immune responses and improved protective outcomes in piglets, supporting its further development as a PEDV vaccine.
SN - 2297-1769
ER -